HTFL HTFL Research And Development Expense Other Than Regulatory And Clinical Expense
Research And Development Expense Other Than Regulatory And Clinical Expense at other companies
Other financials
Where this comes from
Reported directly by HTFL in its filing.
Tagged under the XBRL concept htfl:ResearchAndDevelopmentExpenseOtherThanRegulatoryAndClinicalExpense.
The official record: HTFL’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about HTFL's research and development expense other than regulatory and clinical expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is HTFL's research and development expense other than regulatory and clinical expense?
- HTFL (HTFL) reported research and development expense other than regulatory and clinical expense of $9.67M in Q4 2025.
- How has HTFL's research and development expense other than regulatory and clinical expense changed year-over-year?
- HTFL's research and development expense other than regulatory and clinical expense increased by 48.8% year-over-year, from $6.5M to $9.67M.
- What is the long-term trend for HTFL's research and development expense other than regulatory and clinical expense?
- Over 2 years (2023 to 2025), HTFL's research and development expense other than regulatory and clinical expense has grown at a 31.6% compound annual growth rate (CAGR), from $22.33M to $38.67M.
- What does research and development expense other than regulatory and clinical expense mean?
- Includes all research and development expenditures excluding those specifically tied to regulatory compliance and clinical trials. This metric isolates the core innovation and product development investment from the mandatory costs of bringing a product to market. It is a key indicator of the company's commitment to long-term product pipeline growth.